Drug Type Diagnostic radiopharmaceuticals |
Synonyms- |
Target |
Mechanism IL2RA inhibitors(Interleukin-2 receptor alpha chain inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
T-Cell Lymphoma | Preclinical | ZA | 24 May 2023 |